Evaluating the Efficacy of Temperature-controlled Radiofrequency (TRF) in the Treatment of Vulvovaginal Atrophy.
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This project will be a prospective, multicenter, randomized cohort study. The investigators
will select patients with vulvovaginal atrophy who have indications for treatment, and set up
the experimental group (Peninsula temperature-controlled radiofrequency therapeutic apparatus
group) and the control group (promestriene vaginal soft capsules group). Changes in vaginal
exfoliated cell maturity index (MV), score of vaginal symptoms and signs, vaginal health
index score (VHIS), female sexual function index score (FSFI), visual analogue score (VAS)
before and after treatment, and adverse effects will be observed to analyze the safety and
efficacy of temperature-controlled radiofrequency therapy for vulvovaginal atrophy in
postmenopausal women.